$2.24
-0.23-9.49%
At close: -
$2.22
-0.02-0.89%
After Hours: 7:42 PM EDT
Comments
Loading...
InspireMD Analyst Ratings and Price Targets | NASDAQ:NSPR | Benzinga
InspireMD Inc has a consensus price target of $4.72 based on the ratings of 4 analysts. The high is $5.15 issued by Alliance Global Partners on March 31, 2023. The low is $4 issued by Piper Sandler on May 12, 2025. The 3 most-recent analyst ratings were released by Piper Sandler, Lake Street, and Piper Sandler on May 12, 2025, December 11, 2024, and September 17, 2024, respectively. With an average price target of $4.5 between Piper Sandler, Lake Street, and Piper Sandler, there's an implied 102.70% upside for InspireMD Inc from these most-recent analyst ratings.
Analyst Firms Making Recommendations1
Piper Sandler
Lake Street
National Alliance Securities
Alliance Global Partners
1calculated from analyst ratings
Analyst Ratings for InspireMD
| Buy Now | Get Alert | |||||||
|---|---|---|---|---|---|---|---|---|
| 05/12/2025 | Buy Now | 80.18% | Piper Sandler | Adam Maeder60% | $4.5 → $4 | Maintains | Overweight | Get Alert |
| 12/11/2024 | Buy Now | 125.23% | Lake Street | Frank Takkinen34% | → $5 | Initiates | → Buy | Get Alert |
| 09/17/2024 | Buy Now | 102.7% | Piper Sandler | Adam Maeder60% | $4.5 → $4.5 | Reiterates | Overweight → Overweight | Get Alert |
| 11/02/2023 | Buy Now | 102.7% | Piper Sandler | Adam Maeder60% | $3.5 → $4.5 | Maintains | Overweight | Get Alert |
| 06/12/2023 | Buy Now | 35.14% | Piper Sandler | Adam Maeder60% | → $3 | Initiates | → Overweight | Get Alert |
| 05/17/2023 | Buy Now | 113.96% | National Alliance Securities | Ben Haynor35% | $5.15 → $4.75 | Maintains | Buy | Get Alert |
| 03/31/2023 | Buy Now | 131.98% | Alliance Global Partners | Ben Haynor35% | $5.6 → $5.15 | Maintains | Buy | Get Alert |
FAQ
What is the target price for InspireMD (NSPR) stock?
The latest price target for InspireMD (NASDAQ:NSPR) was reported by Piper Sandler on May 12, 2025. The analyst firm set a price target for $4.00 expecting NSPR to rise to within 12 months (a possible 80.18% upside). 3 analyst firms have reported ratings in the last year.
What is the most recent analyst rating for InspireMD (NSPR)?
The latest analyst rating for InspireMD (NASDAQ:NSPR) was provided by Piper Sandler, and InspireMD maintained their overweight rating.
When was the last upgrade for InspireMD (NSPR)?
There is no last upgrade for InspireMD
When was the last downgrade for InspireMD (NSPR)?
There is no last downgrade for InspireMD.
When is the next analyst rating going to be posted or updated for InspireMD (NSPR)?
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of InspireMD, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for InspireMD was filed on May 12, 2025 so you should expect the next rating to be made available sometime around May 12, 2026.
Is the Analyst Rating InspireMD (NSPR) correct?
While ratings are subjective and will change, the latest InspireMD (NSPR) rating was a maintained with a price target of $4.50 to $4.00. The current price InspireMD (NSPR) is trading at is $2.22, which is out of the analyst’s predicted range.
Browse analyst ratings and price targets on all stocks.
